Global CAR-T Cell Therapy Market Expected to Surge to USD 34.04 Billion by 2034 with a CAGR of 23.33%
March 27, 2024 08:50 ET
|
Research and Markets
Dublin, March 27, 2024 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The global...
France CAR-T Cell Therapy Market Anticipates Impressive Growth Amid Advances in Personalized Medicine and Increase in Hematological Malignancies
February 12, 2024 04:32 ET
|
Research and Markets
Dublin, Feb. 12, 2024 (GLOBE NEWSWIRE) -- The "France CAR-T Cell Therapy Market, By Region, By Competition Forecast & Opportunities, 2018-2028F" report has been added to ...
Blood Cancer Drugs Global Market Research Report 2024
February 06, 2024 09:54 ET
|
Research and Markets
Dublin, Feb. 06, 2024 (GLOBE NEWSWIRE) -- The "Blood Cancer Drugs Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The blood cancer drugs market size has grown...
Global CAR-T Cell Therapy Market Report 2024-2034: Accelerated Growth Fueled by Intensive R&D, Growing Medical Recognition, and Fast Track Designation Regulatory Approvals
January 24, 2024 14:23 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global CAR-T Cell Therapy Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. With the...
Global CAR T-Cell Therapy Research Report 2023: Market Poised for Substantial Growth by 2030, Driven by Advancements in Cancer Treatment and Increasing Incidence Rates
January 24, 2024 04:13 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global CAR T-Cell Therapy Market 2030 by Drug type, Indication, Target Antigen, End-user and Region - Partner & Customer Ecosystem Competitive...
Global CAR T-Cell Therapy Market to Surpass $15 Billion by 2030, Driven by Growing Prevalence of Multiple Myeloma and Lymphoma
December 08, 2023 08:18 ET
|
Research and Markets
Dublin, Dec. 08, 2023 (GLOBE NEWSWIRE) -- The "CAR T-cell Therapy Market Size, Share & Trends Analysis Report by Product (Abecma, Breyanzi), By Disease Indication (Lymphoma, Leukemia, Multiple...
Fortress Biotech Subsidiary Helocyte Announces Option Agreement with City of Hope for Exclusive Worldwide Rights to use a Novel Bispecific CMV/HIV CAR T Cell Therapy (optionally in combination with Triplex) for the Treatment of Adults Living with HIV-1
October 16, 2023 09:00 ET
|
Fortress Biotech, Inc.
Recent $11.3 million grant from the California Institute for Regenerative Medicine (CIRM) intended to fund the Phase 1 clinical trial at City of Hope; the Investigational New Drug application for...
CAR T Cell Therapy Market Size to Hit USD 10.41 Billion by 2027 at 48.96% CAGR – Report by Market Research Future (MRFR)
November 16, 2022 11:00 ET
|
Market Research Future
New York, USA, Nov. 16, 2022 (GLOBE NEWSWIRE) -- CAR T Cell Therapy Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “CAR T Cell Therapy Market...
Chimeric Antigen Receptor CAR T Cell Therapy Cancer Treatment Market Size Report
June 25, 2022 02:34 ET
|
KuicK Research
Singapore, June 25, 2022 (GLOBE NEWSWIRE) -- Global CAR T Cell Therapy Market & Clinical Trials Insight 2028 Report Highlights: Research MethodologyGlobal CAR T Cell Therapy Market Opportunity...
Global CAR T Cell Therapy Market Size Trends Clinical Trials Insight 2028
May 19, 2022 03:55 ET
|
KuicK Research
Singapore, May 19, 2022 (GLOBE NEWSWIRE) -- Global CAR T Cell Therapy Market & Clinical Trials Insight 2028 Report Highlights: Research Methodology Global CAR T Cell Therapy Market...